211At-MABG in Adults With Advanced Neuroendocrine Cancers

Exclusion Criteria

• •1. Women who are pregnant or breast-feeding will not be eligible for this study.
• •2. Inability to tolerate study procedures in the opinion of the investigator or treating physician.
• •3. Serious or unstable medical, psychological, or social conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study.
• •4. Uncontrolled brain metastasis (Participant must be at least 4 weeks since CNS-directed therapy and no longer requiring corticosteroid therapy).
• •5. Anticancer therapy, except hormonal therapy or bone supportive therapies, within 14 days of cycle 1 day 1.
• •6. Has a known additional malignancy (other than the disease under study) that has required active systemic treatment within the past 2 years AND for which the natural history or recent/ongoing treatment could likely interfere with study endpoints or safety of the study treatment per Investigator and Medical Director assessment.